Bain Capital buys Japanese pharma for $3.3B
Bain Capital said the deal came about following several recent initiatives by the Japanese government and regulators to ...
Business Wire2d
Bain Capital Announces Majority Investment in Milacron, a Leading Global Provider of Highly Engineered Plastic Processing Solutions
BOSTON & BATESVILLE, Ind.--(BUSINESS WIRE)--Bain Capital, a leading private investment firm, today announced a majority investment in the Milacron Injection Molding and Extrusion business (or the ...
Bain Capital proposes to take Surgery Partners private
Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it ...
From Bain to Brookfield: Battle for Insignia Sparks Three-Way Bidding War
Brookfield emerges as the third suitor for Insignia, also offering A$3.07 billion and sparking a three-way bidding war for the Aussie wealth manager. Copyright 2025 Thomson Reuters.